Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

E-ISSN： 1996-3181|11|5|610-623

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.11, Iss.5, 2012-08, pp. : 610-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance

By Lu Ellen Wang Bing Wei Guimond Colleen Synnes Anne Sadovnick A Dessa Dahlgren Leanne Traboulsee Anthony Tremlett Helen

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite

Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?

By Weilbach F.X. Gold R.

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 133-157

Adis International

Access to resources Recommend Favorite

The Mechanisms of Action of Disease-Modifying Antirheumatic Drugs: A Review with Emphasis on Macrophage Signal Transduction and the Induction of Proinflammatory Cytokines

By Bondeson J.

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 127-150

Elsevier

Access to resources Recommend Favorite

New antithrombotic drugs on the horizon

By Ruef Johannes Katus Hugo A

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 5, 2003-05 ,pp. : 781-797

Informa Healthcare

Access to resources Recommend Favorite

Epigenetic Drugs for Multiple Sclerosis

Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 3-9

Bentham Science Publishers

Access to resources Recommend Favorite